2017
DOI: 10.11648/j.jddmc.20170303.12
|View full text |Cite
|
Sign up to set email alerts
|

Use of Solid Dispersions and Inclusion Complexation for Enhancing Oral Bioavailability of Ziprasidone in Treating Schizophrenia

Abstract: Abstract:In modern times, people are suffering from many mental health disorders like schizophrenia, bipolar disorders and many psychoses. Hence, it is essential to treat these mental disorders using medications as well as with assistance from caregivers for the social well being of person. This study was focussed on improving solubility & dissolution of poorly soluble drug Ziprasidone using different formulation approaches like solid dispersion & inclusion complexation. Different solubility enhancing techniqu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 40 publications
(41 reference statements)
0
1
0
Order By: Relevance
“…Therefore, nasal drug delivery has been viewed as the suitable route to deliver the drugs that are susceptible to acidic/basic pH or enzymatic hydrolysis. [1][2][3] In addition, it also provides several advantages over the other conventional route of administration. It is non-invasive, rapid and comfortable mode of drug administration, it also bypasses the blood brain barrier (BBB) and targets the central nervous system (CNS) and thus reduces systemic side effects.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, nasal drug delivery has been viewed as the suitable route to deliver the drugs that are susceptible to acidic/basic pH or enzymatic hydrolysis. [1][2][3] In addition, it also provides several advantages over the other conventional route of administration. It is non-invasive, rapid and comfortable mode of drug administration, it also bypasses the blood brain barrier (BBB) and targets the central nervous system (CNS) and thus reduces systemic side effects.…”
Section: Introductionmentioning
confidence: 99%